Gurtoo H L, Dave C V
Cancer Res. 1975 Feb;35(2):382-9.
An aflatoxin B1 metabolite was found to become covalently bound to rat liver RNA and calf thymus DNA in vitro, and it formed complexes with increased spectral absorbance in the 360 nm region. The formation of such complexes was reduced nicotinamide adenine dinucleotide phosphate and microsome dependent, was inhibited by theta-diethylaminoethyl diphenylpropylacetate-HC1, and by CO and N2, when the latter were used to replace the gas phase of the incubations. The formation of the complexes was enhanced about 2-fold with cicrosomes from phenobarbital-treated rats but not from 3-methylcholanthrene-treated rats. More binding was observed with DNA than RNA. Dentured DNA was about 70% as effective as native DNA. Nucleic acids from various sources showed the following order of binding potency: DNA from Micrococcus luteus greater than DNA from calf thymus equal to DNA from rat liver greater than RNA from rat liver greater than transfer RNA from rat liver. In the presence of reduced nicotinamide adenine dinucleotide phosphate and microsomes from phenobarbital-treated rats, aflatoxin G1 was also converted into metabolite(s) that became covalently bound to nucleic acids and formed complexes with increased spectral absorbances in the 360 nm region: this reaction was also inhibited by theta-diethylaminoethyl diphenylpropylacetate-HC1. Under the same conditions, aflatoxin B2, aflatoxin G2, aflatoxin B2a, and "Compound 11," which lack a C2-C3 double bond, did not show any noticeable binding to either DNA or RNA. These data strongly support the concept that the microsomal mixed-funciton oxygenase-catalyzed oxidation of the C2-C3 double bond of aflatoxins is a prerequisite for the formation of nucleic acid-binding metabolites. Microsomes from untreated, phenobarbital-treated, and 3-methylcholanthrene-treated rats were compared in vitro for their ability to catalyze the formation of DNA-binding metabolites from aflatozin B1 and benzo(a)pyrene. In assays involving benzo(a)pyrene, microsomes from 3-methylcholanthrene-treated rats were 12- and 5-fold more active than microsomes from untreated and phenobar-bital-treated rats, respectively. This is in contrast to the results obtained with aflatoxin B1 and suggests that different enzymes in the hepatic microsomal mixed-function oxygenase complex are involved in the generation of reactive metabolites from various polycyclic hydrocarbons.
在体外实验中发现,一种黄曲霉毒素B1代谢产物能与大鼠肝脏RNA及小牛胸腺DNA形成共价结合,并在360nm区域形成吸光度增加的复合物。这种复合物的形成依赖于还原型烟酰胺腺嘌呤二核苷酸磷酸和微粒体,可被盐酸二乙氨基乙基二苯基丙酯抑制,当用一氧化碳和氮气取代孵育体系的气相时也受到抑制。用苯巴比妥处理过的大鼠的微粒体可使复合物的形成增强约2倍,而用3-甲基胆蒽处理过的大鼠的微粒体则无此作用。与RNA相比,DNA上的结合更多。解链DNA的结合效率约为天然DNA的70%。来自不同来源的核酸显示出以下结合能力顺序:藤黄微球菌的DNA>小牛胸腺DNA=大鼠肝脏DNA>大鼠肝脏RNA>大鼠肝脏转移RNA。在存在还原型烟酰胺腺嘌呤二核苷酸磷酸和苯巴比妥处理过的大鼠的微粒体时,黄曲霉毒素G1也会转化为能与核酸形成共价结合并在360nm区域形成吸光度增加的复合物的代谢产物:该反应也可被盐酸二乙氨基乙基二苯基丙酯抑制。在相同条件下,缺乏C2-C3双键的黄曲霉毒素B2、黄曲霉毒素G2、黄曲霉毒素B2a和“化合物11”对DNA或RNA均未显示出明显的结合。这些数据有力地支持了以下观点,即微粒体混合功能氧化酶催化的黄曲霉毒素C2-C3双键氧化是形成核酸结合代谢产物的前提条件。对未处理的、苯巴比妥处理过的和3-甲基胆蒽处理过的大鼠的微粒体在体外催化黄曲霉毒素B1和苯并(a)芘形成DNA结合代谢产物的能力进行了比较。在涉及苯并(a)芘的实验中,用3-甲基胆蒽处理过的大鼠的微粒体活性分别比未处理的和苯巴比妥处理过的大鼠的微粒体高12倍和5倍。这与黄曲霉毒素B1的实验结果相反,表明肝微粒体混合功能氧化酶复合物中的不同酶参与了各种多环芳烃活性代谢产物的生成。